Bay Area/ San Jose/ Real Estate & Development
AI Assisted Icon
Published on December 20, 2023
Healthpeak to Bolster Biotech Hub with 1.3 Million Sq. Ft. Expansion of Vantage Campus in South San FranciscoSource: Healthpeak Properties

Healthpeak Properties, Inc., a major player in healthcare real estate, has secured the rights to expand their Vantage lab development campus in South San Francisco, announced yesterday with plans to add an impressive 1.3 million square feet to their state-of-the-art facilities. Critical to the company's growth strategy, these entitlements will allow the campus to balloon to a whopping 1.7 million square feet of lab space when the project is fully executed; this move is expected to meet the burgeoning demand for biotech innovation spaces.

Located strategically near Genentech's headquarters, the Vantage campus enjoys a prime position, being highly accessible with renovated local transport options and the Rails-to-Trails pathway, tenants of this 20-acre sprawl will have every convenience at their fingertips, including a pedestrian link to South San Francisco's bustling downtown area, teeming with culinary and retail pleasures; this connectivity is no small advantage in the competitive biotech domain. Phase I of the campus is already marking its footprint, with 343,000 rental square feet out of the starting blocks and partially tenanted by Astellas Pharma since December, indicating a steady pace toward full occupancy.

Scott Bohn, Healthpeak's Chief Development Officer and Co-Head of Lab echoed their commitment to fostering a top-tier environment, remarking, "The future phases of Vantage provide Healthpeak a strategic development pipeline to meet the growth needs of our current and future tenants," aiming to secure the firm's foothold in the biotech market for years to come; this sentiment suggests a confidence in the project's synergy with the flourishing South San Francisco biotech scene.

With a history of efficient construction and development, Healthpeak heeds the industry tide, readily flexing its expertise to turn these entitlements into a tangible boon for biotech businesses, and it's a move that not only cements its reputation as a visionary developer but also enforces the significance of South San Francisco as a nexus of biotech ingenuity. Further details on the campus can be garnered from their Vantage website, a central repository for information and updates on the development.